LRN Form 4: EVP granted time- and performance-based equity awards
Rhea-AI Filing Summary
McMullen Greerson Greene, EVP and General Counsel of Stride, Inc. (LRN), acquired equity awards on 08/08/2025 consisting of 2,676 restricted shares and 1,004 restricted stock rights. The restricted shares vest semi-annually with 20% vesting in the first year and 40% vesting in each of the next two years. The restricted stock rights are performance-based and will vest only if certain compound annual growth rates in the company’s common stock price are achieved by 09/15/2028; the amount reported represents the threshold award.
The grants were made at a $0 price and are reported as directly beneficially owned following the transactions, with 13,426 shares of common stock held directly and 1,004 restricted stock rights outstanding. These awards combine time-based and performance-based vesting conditions for executive compensation.
Positive
- Grant of 2,676 restricted shares with a clear time-based vesting schedule (20% first year; 40% in each of the following two years).
- Grant of 1,004 performance-based restricted stock rights that vest only if specified compound annual growth rate targets in the company’s stock price are met by 09/15/2028.
Negative
- None.
Insights
TL;DR: Routine executive equity grants: time-based restricted shares and performance rights reported at $0, reflecting compensation, not a sale.
The filing shows an award of 2,676 restricted shares with a detailed 20%/40%/40% vesting schedule and 1,004 performance-contingent restricted stock rights tied to stock-price CAGR through 09/15/2028. Both awards are reported as directly beneficially owned and granted at no cash price ($0). From a securities perspective this is a standard compensation grant disclosed under Section 16 and signals management alignment via time and performance vesting rather than a liquidity event.
TL;DR: Compensation structure mixes time-based vesting and stock-price performance hurdles, aligning long-term incentives for the reporting executive.
The reported awards incorporate a time-based restricted share tranche (semi-annual vesting, 20% first year, then 40%/40%) and a performance-based tranche